PuSH - Publication Server of Helmholtz Zentrum München

Ziegler, A.-G. ; Bonifacio, E.* ; Powers, A.C.* ; Todd, J.A.* ; Harrison, L.C.* ; Atkinson, M.A.*

Type 1 diabetes prevention: A goal dependent on accepting a diagnosis of an asymptomatic disease.

Diabetes 65, 3233-3239 (2016)
Publ. Version/Full Text DOI
Free by publisher
Open Access Green as soon as Postprint is submitted to ZB.
Type 1 diabetes, a disease defined by absolute insulin deficiency, is considered a chronic autoimmune disorder resulting from the destruction of insulin-producing pancreatic b-cells. The incidence of childhood-onset type 1 diabetes has been increasing at a rate of 3%-5% per year globally. Despite the introduction of an impressive array of therapies aimed at improving disease management, no means for a practical cure exist. This said, hope remains high that any of a number of emerging technologies (e.g., continuous glucose monitoring, insulin pumps, smart algorithms), alongside advances in stem cell biology, cell encapsulation methodologies, and immunotherapy, will eventually impact the lives of those with recently diagnosed or established type 1 diabetes. However, efforts aimed at reversing insulin dependence do not address the obvious benefits of disease prevention. Hence, key stretch goals for type 1 diabetes research include identifying improved and increasingly practical means for diagnosing the disease at earlier stages in its natural history (i.e., early, presymptomatic diagnosis), undertaking such efforts in the population at large to optimally identify those with presymptomatic type 1 diabetes, and introducing safe and effective therapeutic options for prevention.
Altmetric
Additional Metrics?
[➜Log in]
Edit extra informations Login
Publication type Article: Journal article
Document type Scientific Article
Corresponding Author
Keywords Antibody Standardization Program; Islet Autoantibodies; Children; Risk; Ketoacidosis; Adolescents; Progression; Childhood; Insulin; Assays
ISSN (print) / ISBN 0012-1797
e-ISSN 1939-327X
Journal Diabetes
Quellenangaben Volume: 65, Issue: 11, Pages: 3233-3239 Article Number: , Supplement: ,
Publisher American Diabetes Association
Publishing Place Alexandria, VA.
Non-patent literature Publications
Reviewing status Peer reviewed
Institute(s) Institute of Diabetes Research Type 1 (IDF)